This research blend combines CJC-1295 without DAC (Modified GRF 1-29), a synthetic analogue of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue. Each vial contains 5mg CJC-1295 no DAC + 5mg Ipamorelin (10mg total).
CJC-1295 no DAC acts on GHRH receptors to stimulate pulsatile growth hormone release, while Ipamorelin selectively mimics ghrelin at the GHS-R1a receptor without significantly affecting cortisol or prolactin levels. Research suggests the combination may produce synergistic effects on growth hormone secretion patterns.
CJC-1295 no DAC — Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg
Ipamorelin — Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Supplied as a lyophilised (freeze-dried) powder for reconstitution with bacteriostatic water prior to use in research settings. Certificate of Analysis available on request.
For research use only. Not intended for human or veterinary use. UK delivery via Royal Mail 1st Class Recorded.
Important: This product is intended for research purposes only. Not for human or veterinary use. Must be handled by qualified personnel in appropriate laboratory settings.